Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Mechanism of stilbene compounds on the improvement of insulin resistance of adipocytes by NLRP3 inflammasome
Hits 550  Download times 256  Received:January 25, 2025  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2025.06.15
Key Words   stilbene compounds;insulin resistance;NLRP3 inflammasome;inflammation;network pharmacology
Author NameAffiliationE-mail
ZHANG Bo School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
XU Yifang School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
YUAN Yongkang School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
CAO Shijie State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
KANG Ning School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China kangndd@163.com 
Abstract
    [Objective] To investigate the mechanism of stilbene compounds,including resveratrol(Re),mulberroside A(SP),and polygonum multiflorum glycosides(HSW),from three traditional Chinese medicines on the improvement of insulin resistance(IR) of adipocytes. [Methods] Network pharmacology was used to predict the potential therapeutic targets of the tested compounds;insulin resistant 3T3-L1 adipocytes model(IR-3T3-L1) was established by the stimulation of tumor necrosis factor α(TNF-α);after pretreated with NLRP3(NOD-like receptor pyrin domain containing 3) inhibitor MCC950,the growth inhibitory effect and glucose consumption of the tested compound on the IR-3T3-L1 cells were determined by thiazole blue(MTT) method and Glucose oxidase method,respectively;molecular docking and cell thermal shift assay(CETSA) were used to investigate the binding of NLRP3 with Re,SP and HSW;Western Blot was used to test the expression of NLRP3 inflammasome-related protein;reverse transcription-quantitative polymerase chain reaction(RT-qPCR) was performed to investigate the mRNA expression of inflammatory factors. [Results] The results of network pharmacology analysis indicated that NOD-like receptor signaling pathway might play an important role in the beneficial effects of Re,SP,and HSW on inflammation and diabetes mellitus;the addition of MCC950 further increased the glucose uptake compared with Re,SP,HSW alone treatment;the results of molecular docking and CETSA showed that SP,HSW could bind to NLRP3;compared with the control group,the protein expression of NLRP3 and cleaved caspase-1(cle-caspase 1) in the model group was upregulated,and the pro-caspase 1 protein was downregulated. Meanwhile TNF-α significantly upregulated the mRNA expression of interleukin-1β(IL-1β),interleukin-6(IL-6) and interleukin-18(IL-18),and downregulated the mRNA expression of adiponectin(Adipoq);but compared with the model group,Re,SP and HSW could significantly decrease the protein expressions of NLRP3,while SP and HSW significantly increased the protein expression of pro-caspase 1,and HSW significantly reduced the protein expression of cle-caspase 1. In addition,compared with the model group,Re significantly inhibited the mRNA expression of IL-6,IL-18 and IL-1β,and SP decreased the mRNA expression of IL-6 and IL-18,and HSW significantly decreased the mRNA expression of IL-1β. [Conclusion] Re,SP and HSW exhibited anti-diabetic effects through suppressing inflammatory responses and improving IR of adipocytes by inhibition of NLRP3 inflammasome.

You are the 4067006 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.